Search Tag: Triple-Negative Breast Cancer
2024 18 Apr
The stiffness of triple-negative breast tumours influences the aggressiveness of cancer cells and their ability to spread to other organs, according to research from the Garvan Institute of Medical Research. Soft tumour environments prime cancer cells for survival during metastasis by triggering an alternative form of metabolism. A recent study...Read more
2024 18 Apr
The stiffness of triple-negative breast tumours influences the aggressiveness of cancer cells and their ability to spread to other organs, according to research from the Garvan Institute of Medical Research. Soft tumour environments prime cancer cells for survival during metastasis by triggering an alternative form of metabolism. A recent study...Read more
2022 13 Jan
Triple-Negative Breast Cancers (TNBCs) are more challenging to treat because they are not driven by estrogen receptors, progesterone receptors, or excess HER2 protein, typical targets for breast cancer therapeutics. Thus no standard therapy has shown proven efficacy for treating this patient population. Furthermore, this group of patients, which account...Read more